BioCardia, Inc. (BCDA)
1.11
+0.03
(+2.78%)
USD |
NASDAQ |
Sep 08, 16:00
1.12
+0.01
(+0.90%)
Pre-Market: 20:00
BioCardia Net Income (Quarterly) : -1.613M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.613M |
| March 31, 2026 | -2.259M |
| December 31, 2025 | -1.984M |
| September 30, 2025 | -1.483M |
| June 30, 2025 | -2.049M |
| March 31, 2025 | -2.712M |
| December 31, 2024 | -2.296M |
| September 30, 2024 | -1.737M |
| June 30, 2024 | -1.646M |
| March 31, 2024 | -2.267M |
| December 31, 2023 | -2.072M |
| September 30, 2023 | -2.574M |
| June 30, 2023 | -3.424M |
| March 31, 2023 | -3.501M |
| December 31, 2022 | -3.028M |
| September 30, 2022 | -3.057M |
| June 30, 2022 | -2.497M |
| March 31, 2022 | -3.325M |
| December 31, 2021 | -3.461M |
| September 30, 2021 | -2.706M |
| June 30, 2021 | -3.487M |
| March 31, 2021 | -2.969M |
| December 31, 2020 | -2.989M |
| September 30, 2020 | -3.848M |
| June 30, 2020 | -3.573M |
| Date | Value |
|---|---|
| March 31, 2020 | -4.594M |
| December 31, 2019 | -3.501M |
| September 30, 2019 | -3.792M |
| June 30, 2019 | -3.75M |
| March 31, 2019 | -3.665M |
| December 31, 2018 | -3.642M |
| September 30, 2018 | -3.544M |
| June 30, 2018 | -3.217M |
| March 31, 2018 | -3.584M |
| December 31, 2017 | -3.486M |
| September 30, 2017 | -3.001M |
| June 30, 2017 | -2.945M |
| March 31, 2017 | -2.876M |
| September 30, 2016 | -3.254M |
| June 30, 2016 | -1.978M |
| March 31, 2016 | -1.496M |
| December 31, 2015 | 0.09M |
| September 30, 2015 | 0.083M |
| June 30, 2015 | 0.073M |
| March 31, 2015 | 0.076M |
| December 31, 2014 | 0.061M |
| September 30, 2014 | 0.043M |
| June 30, 2014 | 0.066M |
| March 31, 2014 | 0.064M |
| December 31, 2013 | 0.005M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cytokinetics, Inc. | -198.76M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 1.613M |
| EPS Diluted (Quarterly) | -0.1334 |
| Enterprise Value | 12.81M |
| Earnings Yield | -68.74% |
| Normalized Earnings Yield | -68.74 |